BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38718867)

  • 1. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis.
    Radisky ES
    J Biol Chem; 2024 Jun; 300(6):107347. PubMed ID: 38718867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Peptidome and Tumor-Resident Proteolysis.
    Fan J; Ning B; Lyon CJ; Hu TY
    Enzymes; 2017; 42():1-25. PubMed ID: 29054266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe.
    Greco MR; Antelmi E; Busco G; Guerra L; Rubino R; Casavola V; Reshkin SJ; Cardone RA
    Oncol Rep; 2014 Feb; 31(2):940-6. PubMed ID: 24337203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
    Skrzydlewska E; Sulkowska M; Koda M; Sulkowski S
    World J Gastroenterol; 2005 Mar; 11(9):1251-66. PubMed ID: 15761961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression.
    Verbovšek U; Van Noorden CJ; Lah TT
    Semin Cancer Biol; 2015 Dec; 35():71-84. PubMed ID: 26320409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
    Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.
    Doucet A; Butler GS; Rodríguez D; Prudova A; Overall CM
    Mol Cell Proteomics; 2008 Oct; 7(10):1925-51. PubMed ID: 18596063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining metalloproteases specificity through network proteolysis.
    Kollet O; Das A; Karamanos N; Auf dem Keller U; Sagi I
    Trends Mol Med; 2024 Feb; 30(2):147-163. PubMed ID: 38036391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
    Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
    Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.
    Kee NL; Krause J; Blatch GL; Muramoto K; Sakka K; Sakka M; Naudé RJ; Wagner L; Wolf R; Rahfeld JU; Demuth HU; Mielicki WP; Frost CL
    Protein J; 2015 Oct; 34(5):338-48. PubMed ID: 26341972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional imaging of tumor proteolysis.
    Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
    Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging and quantifying the dynamics of tumor-associated proteolysis.
    Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
    Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled extracellular proteolysis of thrombospondins.
    Carminati L; Carlessi E; Longhi E; Taraboletti G
    Matrix Biol; 2023 May; 119():82-100. PubMed ID: 37003348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer: Proteolysis and Migration.
    Osuala KO; Ji K; Mattingly RR; Sloane BF
    Adv Exp Med Biol; 2019; 1152():401-411. PubMed ID: 31456196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis.
    Yuzhalin AE; Lim SY; Kutikhin AG; Gordon-Weeks AN
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):207-228. PubMed ID: 30316942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteases: Pivot Points in Functional Proteomics.
    Verhamme IM; Leonard SE; Perkins RC
    Methods Mol Biol; 2019; 1871():313-392. PubMed ID: 30276748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.
    Salcedo EC; Winter MB; Khuri N; Knudsen GM; Sali A; Craik CS
    ACS Chem Biol; 2021 Apr; 16(4):712-723. PubMed ID: 33765766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.